Changeflow GovPing Pharma & Drug Safety USPTO Grants Patent for Food Composition Improv...
Routine Notice Added Final

USPTO Grants Patent for Food Composition Improving Motor Function

Favicon for changeflow.com ChangeBridge: Patent Grants - Pharma (A61K)
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has granted a new patent (US12582704B2) to PICOENTECH Co., LTD. for a food or pharmaceutical composition designed to improve behavioral and motor function. The composition contains aldehyde dehydrogenase, which helps reduce aldehydes produced by alcohol oxidation, and is derived from specific strains of Saccharomyces cerevisiae.

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582704B2 for a food or pharmaceutical composition aimed at improving behavioral and motor function. The patent, assigned to PICOENTECH Co., LTD., specifically covers compositions containing aldehyde dehydrogenase derived from certain Saccharomyces cerevisiae strains, which are intended to inhibit or prevent conditions like Parkinson's disease by reducing aldehydes produced from alcohol oxidation.

This patent grant is primarily an informational event for the pharmaceutical and food manufacturing sectors. While it does not impose new regulatory obligations, it signifies innovation in the development of functional foods and potential therapeutic agents. Companies involved in related research and development should be aware of this granted patent, particularly if their work involves aldehyde dehydrogenase or treatments for motor function disorders.

Source document (simplified)

← USPTO Patent Grants

Food composition for improving behavioral and motor function containing aldehyde dehydrogenase for reducing aldehydes produced by oxidation of alcohol

Grant US12582704B2 Kind: B2 Mar 24, 2026

Assignee

PICOENTECH Co., LTD.

Inventors

Hung Taeck Kwon

Abstract

Food or pharmaceutical compositions for improving behavior and motor function and to pharmaceutical composition for inhibiting or preventing Parkinson's disease, containing an aldehyde dehydrogenase encoded by a gene having more than 98% homology to the gene of SEQ ID NO: 1, encoded by the gene of SEQ ID NO: 1 including SEQ ID NO: 2, which is contained in lysate of any one or a mixture thereof selected from Saccharomyces cerevisiae, KCTC13925BP, KCTC14122BP, KCTC14123BP, KCTC14983BP, KCTC14984BP and KCTC14985BP.

CPC Classifications

A61K 2236/19

Filing Date

2024-08-09

Application No.

18799019

Claims

5

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582704B2

Who this affects

Applies to
Drug manufacturers Food manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3114 Food & Beverage Manufacturing
Activity scope
Drug Development Food Composition Development
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
R&D
Topics
Food Safety Medical Research

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.